- ICH GCP
- Register voor klinische proeven in de VS.
- Search trials
Klinische onderzoeken gesponsord door Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Totaal 2265 resultaten
-
Academy Military Medical Science, ChinaCancer Institute and Hospital, Chinese Academy of Medical SciencesOnbekend
-
Cancer Institute and Hospital, Chinese Academy...Nog niet aan het werven
-
Cancer Institute and Hospital, Chinese Academy...WervingHersenmetastasenChina
-
Cancer Institute and Hospital, Chinese Academy...WervingMaagkanker | Diffuus type carcinoomChina
-
Cancer Institute and Hospital, Chinese Academy...Werving
-
Cancer Institute and Hospital, Chinese Academy...Werving
-
Cancer Institute and Hospital, Chinese Academy...Werving
-
Cancer Institute and Hospital, Chinese Academy...WervingLokaal gevorderde niet-kleincellige longkankerChina
-
Cancer Institute and Hospital, Chinese Academy...WervingLongkanker | Niet-kleincellige longkanker | Longadenocarcinoom | Kleincellige longkanker | LongplaveiselcelcarcinoomChina
-
Cancer Institute and Hospital, Chinese Academy...WervingHepatocellulair carcinoom | Radiotherapie | Smalle margeChina
-
Cancer Institute and Hospital, Chinese Academy...WervingChemotherapeutische toxiciteit | Radiotherapie; complicaties | PARP-remmer | Immuun Checkpoint-remmer | Trastuzumab | Borstkanker, familiale man | CDK4/6-remmer | PertuzumabChina
-
Cancer Institute and Hospital, Chinese Academy...WervingThymus NeoplasmataChina
-
Cancer Institute and Hospital, Chinese Academy...WervingLokaal gevorderd colorectaal carcinoomChina
-
Cancer Institute and Hospital, Chinese Academy...WervingRefractaire vaste tumoren | Recidiverende solide tumorenChina
-
Cancer Institute and Hospital, Chinese Academy...Nog niet aan het wervenKanker | Katheter complicaties | Trombose, veneusChina
-
Cancer Institute and Hospital, Chinese Academy...WervingHerhaling | Chirurgie | SchildklierkankerChina
-
Cancer Institute and Hospital, Chinese Academy...Werving
-
Cancer Institute and Hospital, Chinese Academy...Nog niet aan het werven
-
Cancer Institute and Hospital, Chinese Academy...WervingBevacizumab | Capecitabine | Gemetastaseerde colorectale kanker (mCRC) | Oxaliplatine | Tislelizumab | Eerste lijn | MSS/pMMR | RAS-gemuteerdChina
-
Cancer Institute and Hospital, Chinese Academy...WervingCovid-19-vaccin | Covid-19-besmettingChina
-
Cancer Institute and Hospital, Chinese Academy...WervingBorstkanker | Bijwerking van radiotherapieChina
-
Cancer Institute and Hospital, Chinese Academy...Werving
-
Cancer Institute and Hospital, Chinese Academy...Werving
-
Cancer Institute and Hospital, Chinese Academy...WervingHoofd-halskanker | Straling dermatitisChina
-
Cancer Institute and Hospital, Chinese Academy...Werving
-
Cancer Institute and Hospital, Chinese Academy...Werving
-
Cancer Institute and Hospital, Chinese Academy...Werving
-
Cancer Institute and Hospital, Chinese Academy...Nog niet aan het wervenRadiotherapie | Rectale neoplasmata KwaadaardigChina
-
Cancer Institute and Hospital, Chinese Academy...WervingGemetastaseerde neus-keelholtekankerChina
-
Cancer Institute and Hospital, Chinese Academy...WervingHormoonreceptorpositieve gevorderde borstkankerChina
-
Cancer Institute and Hospital, Chinese Academy...Werving
-
Cancer Institute and Hospital, Chinese Academy...Werving
-
Cancer Institute and Hospital, Chinese Academy...Nog niet aan het werven
-
Cancer Institute and Hospital, Chinese Academy...Nog niet aan het wervenDarmkanker stadium IV | Hand- en voethuidreactieChina
-
Cancer Institute and Hospital, Chinese Academy...WervingColorectale neoplasmata KwaadaardigChina
-
Cancer Institute and Hospital, Chinese Academy...WervingWekedelensarcoom | Bijwerking van radiotherapie | Retroperitoneaal sarcoom | Ultra-gehypofractioneerde radiotherapie | Stereotactische ablatieve radiotherapieChina
-
Cancer Institute and Hospital, Chinese Academy...WervingProstaatkanker | Bijwerking van radiotherapie | Oligometastatische ziekte | Magnetische resonantie-linac | Stereotactische ablatieve RT | Adaptieve radiotherapie | Gelokaliseerde ziekteChina
-
Cancer Institute and Hospital, Chinese Academy...Nog niet aan het wervenBaarmoederhalskanker stadium IB1China
-
Cancer Institute and Hospital, Chinese Academy...WervingAnlotinib | Sarcoom, zacht weefsel | Kofferbak | Uiteinde | Intensiteitsgemoduleerde radiotherapie | Ernstige wondcomplicatiesChina
-
Cancer Institute and Hospital, Chinese Academy...WervingGemetastaseerde triple-negatieve borstkankerChina
-
Cancer Institute and Hospital, Chinese Academy...Werving
-
Cancer Institute and Hospital, Chinese Academy...Nog niet aan het wervenBorstkanker in een vergevorderd stadium
-
Cancer Institute and Hospital, Chinese Academy...Nog niet aan het werven
-
Cancer Institute and Hospital, Chinese Academy...WervingChemoradiatie | Chemotherapie-effect | Immunotherapie | Gerichte therapie | Slokdarmkanker | SlokdarmkankerChina
-
Cancer Institute and Hospital, Chinese Academy...WervingKleincellig longcarcinoomChina
-
Cancer Institute and Hospital, Chinese Academy...Nog niet aan het werven
-
Cancer Institute and Hospital, Chinese Academy...WervingSlokdarm plaveiselcelcarcinoomChina
-
Cancer Institute and Hospital, Chinese Academy...WervingRecidiverend nasofarynxcarcinoom | Gemetastaseerd nasofarynxcarcinoomChina
-
Cancer Institute and Hospital, Chinese Academy...Actief, niet wervendBaarmoederhalskankerChina
-
Cancer Institute and Hospital, Chinese Academy...VoltooidSlokdarmkanker | Inoperabel maligne neoplasma | Chemoradiotherapie | NimotuzumabChina